Skip to main content
. 2021 Mar 16;21:48. doi: 10.1186/s12902-021-00711-y

Table 2.

Healthcare characteristics of diabetes participants in Brazil and Mexico surveys

Countries
Brazil
n (%)
Mexico
n (%)
Total
n (%)
X2 df P*
Access to medical care
 No 931 (25.6) 267 (5.8) 1198 (14.6) 182.551 1 < 0.0001
 Yes 2705 (74.3) 4288 (94.1) 6993 (85.3)
Type of medical care
 Private 768 (21.1) 680 (14.9) 1448 (17.6) 184.233 3 < 0.0001
 Public 1915 (52.6) 3371 (74.0) 5286 (64.5)
 Do not receive 931 (25.6) 267 (5.8) 1198 (14.6)
 Other 22 (0.6) 237 (5.2) 259 (3.1)
Type of diabetes treatment
 None 742 (20.4) 600 (13.1) 1306 (15.9) 229.920 3 < 0.0001
 Insulin 162 (4.4) 339 (7.4) 401 (4.8)
 Oral medications 2253 (61.9) 3397 (74.5) 5650 (68.9)
 Both 479 (13.1) 290 (6.3) 769 (9.3)
Measurement of venous glucose
 No 717 (19.7) 2707 (59.4) 3424 (41.8) 1474.135 1 < 0.0001
 Yes 2919 (80.2) 1848 (40.5) 4767 (58.2)
Use of glucose strips (glucometer)
 No 1631 (44.8) 3238 (71.0) 4869 (59.4) 914.141 1 < 0.0001
 Yes 2005 (55.1) 1317 (28.9) 3322 (40.6)
HbA1C
 No 1403 (38.5) 3654 (80.2) 5057 (61.7) 3126.558 1 < 0.0001
 Yes 2233 (61.4) 901 (19.7) 3134 (38.2)
Urinalysis
 No 1102 (30.3) 2675 (58.7) 3777 (46.2) 1618.638 1 < 0.0001
 Yes 2534 (69.6) 1880 (41.3) 4414 (53.8)
Foot exam
 No 1821 (50.0) 3395 (74.6) 5216 (63.7) 1661.402 1 < 0.0001
 Yes 1815 (49.9) 1161 (25.4) 2976 (36.3)

df degrees freedom, *X2 Test